Medication Safety Practice Corner Key learnings: Preventing errors with intravenous acetylcysteine
Canadian Journal of Critical Care Nursing · 2023
DOI: 10.5737/23688653-3449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Critical Care Nursing, 2023. Verfasst von Carolyn Hoffman und 3 weiteren Autor:innen.
Themen: Medikationssicherheit
Abstract (Originalsprache)
ISMP Canada received three reports of death or severe harm involving intravenous acetylcysteine (also known as N-acetylcysteine) overdose related to one type of error—continuation of the loading dose IV infusion rate instead of reduction to a lower rate for the maintenance dose. All resulted in a 10-fold dosing error. An alert was published in 2022, and a follow-up safety bulletin in 2023 shared findings from a multi-incident analysis with recommendations (ISMP Canada, 2022 & 2023). There are many protocols/regimens in use across Canada for the preparation and administration of acetylcysteine, each with potential benefits and risks. This column shares key findings and several strategies to support the safe administration of acetylcysteine. Critical care nurses’ specialized expertise in patient monitoring and fluid management is vital for optimal care outcomes.
Zitieren
APA
Hoffman, C., Hyland, S., Harber, M., & Riley, L. (2023). Medication Safety Practice Corner Key learnings: Preventing errors with intravenous acetylcysteine. Canadian Journal of Critical Care Nursing. https://doi.org/10.5737/23688653-3449
Vancouver
Hoffman C, Hyland S, Harber M, Riley L. Medication Safety Practice Corner Key learnings: Preventing errors with intravenous acetylcysteine. Canadian Journal of Critical Care Nursing. 2023. doi:10.5737/23688653-3449
BibTeX
@article{Hoffman2023,
author = {Hoffman, Carolyn and Hyland, Sylvia and Harber, Mary and Riley, Lynn},
title = {Medication Safety Practice Corner Key learnings: Preventing errors with intravenous acetylcysteine},
journal = {Canadian Journal of Critical Care Nursing},
year = {2023},
doi = {10.5737/23688653-3449}
}
EUVIMED